Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Indoleamine 2,3-dioxygenase (IDO) is induced by proinflammatory cytokines and by CTLA-4-expressing T cells and constitutes an important mediator of peripheral immune tolerance. In chronic hepatitis C, we found upregulation of IDO expression in the liver and an increased serum kynurenine/tryptophan r...

Bibliografiset tiedot
Päätekijät:	Larrea, E, Riezu-Boj, J, Gil-Guerrero, L, Casares, N, Aldabe, R, Sarobe, P, Civeira, M, Heeney, J, Rollier, C, Verstrepen, B, Wakita, T, Borrás-Cuesta, F, Lasarte, J, Prieto, J
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2007

Samankaltaisia teoksia

Indoleamine 2,3-dioxygenase in endometriosis
Tekijä: Hui-Li Yang, et al.
Julkaistu: (2019-01-01)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
Tekijä: Lieve Brochez, et al.
Julkaistu: (2021-12-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
Tekijä: Mona F.M El-Karn, et al.
Julkaistu: (2016-01-01)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
Tekijä: Röhrig, U, et al.
Julkaistu: (2010)

Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration.
Tekijä: Chun-Sing Lam, et al.
Julkaistu: (2017-01-01)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
Tekijä: Aleksandar Acovic, et al.
Julkaistu: (2018-12-01)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
Tekijä: Andrew L. Mellor, et al.
Julkaistu: (2017-10-01)

Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1
Tekijä: Asha M. Rudjord-Levann, et al.
Julkaistu: (2023-07-01)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
Tekijä: Quan, J, et al.
Julkaistu: (2008)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
Tekijä: Quan, J, et al.
Julkaistu: (2008)

Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.
Tekijä: Kudo, Y, et al.
Julkaistu: (2004)

Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia.
Tekijä: Kudo, Y, et al.
Julkaistu: (2003)

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
Tekijä: Orabona, C, et al.
Julkaistu: (2018)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
Tekijä: Chiara Suvieri, et al.
Julkaistu: (2024-11-01)

Research progress of indoleamine 2,3-dioxygenase 1 in gastric cancer
Tekijä: Pei Xiaxia, et al.
Julkaistu: (2023-03-01)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
Tekijä: Camilla Grønkjær Jensen, et al.
Julkaistu: (2021-07-01)

Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
Tekijä: Asim Farooq, et al.
Julkaistu: (2022-09-01)

Comprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
Tekijä: Nao Hirata, et al.
Julkaistu: (2018-09-01)

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
Tekijä: Yuhei Shibata, et al.
Julkaistu: (2016-01-01)

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
Tekijä: Ding Ya, et al.
Julkaistu: (2009-08-01)

Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
Tekijä: Tao Zhang, et al.
Julkaistu: (2017-01-01)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
Tekijä: Lilla Hornyák, et al.
Julkaistu: (2018-01-01)

Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
Tekijä: Corina Bello, et al.
Julkaistu: (2021-11-01)

Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy
Tekijä: Ning Deng, et al.
Julkaistu: (2021-02-01)

Highly Efficient Stable Expression of Indoleamine 2,3 Dioxygenase Gene in Primary Fibroblasts
Tekijä: Rezakhanlou Alireza, et al.
Julkaistu: (2010-03-01)

IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression
Tekijä: Hanako Ohmatsu, et al.
Julkaistu: (2017-02-01)

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
Tekijä: Christiane A Opitz, et al.
Julkaistu: (2011-01-01)

Indoleamine 2,3 dioxygenase activity aggravates the course and pathology of murine tuberculosis
Tekijä: Guo, L, et al.
Julkaistu: (2018)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
Tekijä: V. A. Kozlov, et al.
Julkaistu: (2017-07-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
Tekijä: Cemil Bilir, M.D., et al.
Julkaistu: (2017-07-01)

Serum indoleamine 2,3-dioxygenase level and diagnostic value in patients with rosacea
Tekijä: Merve Sena Odabasi, et al.
Julkaistu: (2023-01-01)

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.
Tekijä: Shamaila Munir, et al.
Julkaistu: (2012-01-01)

Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer
Tekijä: Anshuman Panda, et al.
Julkaistu: (2021-07-01)

Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries
Tekijä: Lingyan Xu, et al.
Julkaistu: (2021-11-01)

Tolerance induction by monoclonal CD3 antibodies is dependent on indoleamine 2,3 dioxygenase (IDO)
Tekijä: Kuhn, C, et al.
Julkaistu: (2012)

Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
Tekijä: Weirui Li, et al.
Julkaistu: (2021-02-01)

Modulation of indoleamine 2,3-dioxygenase by interferon-gamma in human placental chorionic villi.
Tekijä: Kudo, Y, et al.
Julkaistu: (2000)

Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.
Tekijä: Kudo, Y, et al.
Julkaistu: (2001)

Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma
Tekijä: Heike Loeser, et al.
Julkaistu: (2020-01-01)

Correlation of Indoleamine-2,3-Dioxygenase and Chronic Kidney Disease: A Pilot Study
Tekijä: Binbin Pan, et al.
Julkaistu: (2021-01-01)